Targeting on the PI3K/mTOR: a potential treatment strategy for clear cell ovarian carcinoma
This study comprehensively assessed the efficacy of WX390 across multiple models of OCCC, laying a solid foundation for the development of new therapeutic strategies for this challenging malignancy.
Authors
- Yu Kang (ORCID: https://orcid.org/0000-0003-1197-4727)
- Yi Gao (ORCID: https://orcid.org/0000-0003-3634-8087)
- Jing Xu (ORCID: https://orcid.org/0009-0004-7045-8161)
- Rui Cao (ORCID: https://orcid.org/0000-0002-2211-0652)
- Kewei Zheng (ORCID: https://orcid.org/0009-0002-5479-2544)
- Ranran Chai
- Guanqin Jin (ORCID: https://orcid.org/0000-0001-8104-5718)
Institutions
- Obstetrics and Gynecology Hospital of Fudan University (CN)
Publication Details
- Journal
- Cancer Chemotherapy and Pharmacology
- Published
- 2025-01-10
- DOI
- https://doi.org/10.1007/s00280-024-04748-3
- Citations
- 4
- Primary Topic
- Autophagy in Disease and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 5.42
Funders
- National Key Research and Development Program of China